Key result
The 3.2-kb allele in the apolipoprotein C-III gene was found in a increased prevalence among Caucasian hypertriglyceridemic subjects compared to race-matched controls (0).
Why the study?
Is a DNA sequence polymorphism in the apolipoprotein C-III gene associated with hypertriglyceridemia in Caucasian subjects?
Case-Control (n=215)
Is a DNA sequence polymorphism in the apolipoprotein C-III gene associated with hypertriglyceridemia in Caucasian subjects?
A specific DNA polymorphism in the apolipoprotein C-III gene is significantly associated with hypertriglyceridemia in Caucasian populations.
Answers are grounded in this paper and cite their sources.
No immediate change to hypertriglyceridemia management; leaves open causal role of the 3.2-kb allele.
A DNA sequence polymorphism, revealed by digestion of human DNA with the restriction endonuclease Sst-1 and hybridization with an apolipoprotein A-I complementary DNA clone, has been shown to be located in or close to the 3' noncoding region of the apolipoprotein C-III gene. This polymorphism is found in significantly increased prevalence (P less than 0.001) in Caucasian hypertriglyceridemic subjects compared with race-matched controls, and its distribution in normal individuals of differing racial origins is reported. Furthermore, no alteration of high density lipoprotein or apolipoprotein A-I and apolipoprotein C-III phenotypes was observed in individuals with or without the polymorphism.
No takes yet. Share an insight, caveat, or question.
Rees et al. (1985) conducted a case-control in Hypertriglyceridemia (n=215). Sst-1 polymorphism (3.2-kb allele) in the apolipoprotein A-1-C-III gene cluster vs. Absence of the 3.2-kb allele (common 4.2-kb allele) was evaluated on Frequency of the 3.2-kb allele (p=<0.001). The 3.2-kb allele in the apolipoprotein C-III gene was found in a increased prevalence among Caucasian hypertriglyceridemic subjects compared to race-matched controls (0).
Synapse has enriched 10 related papers. Consider them for comparative context: